Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective

被引：2
|
作者：
Luster, Markus [1 ]
Schlumberger, Martin [2 ]
Pacini, Furio [3 ]
机构：
[1] Univ Ulm, Dept Nucl Med, D-89081 Ulm, Germany
[2] Inst Gustave Roussy, Dept Nucl Med & Endocrine Oncol, F-94805 Villejuif, France
[3] Univ Siena, Sect Endocrinol & Metab, Dept Internal Med, I-53100 Siena, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷 / 02期
关键词：
HORMONE WITHDRAWAL; RADIOIODINE THERAPY; MANAGEMENT; CARCINOMA; DOSIMETRY; ABLATION;
D O I：
10.1007/s00259-008-1013-9
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：329 / 330
页数：2
相关论文
共 50 条
  • [31] Differentiated Thyroid Carcinoma: Is There Any Evidence for the Use of Recombinant Human TSH in Thyroid Hormone-Secreting Metastasis?
    Schneider, Christina
    Kahraman, Deniz
    Kobe, Carsten
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (08) : 1329 - 1330
  • [32] Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer
    Durski, JM
    Weigel, RJ
    McDougall, IR
    NUCLEAR MEDICINE COMMUNICATIONS, 2000, 21 (06) : 521 - 528
  • [33] Present status of the use of recombinant human TSH in thyroid cancer management
    Luster, Markus
    ACTA ONCOLOGICA, 2006, 45 (08) : 1018 - 1030
  • [34] Usefulness of recombinant human TSH aided radioiodine doses administered in patients with differentiated thyroid carcinoma
    Pitoia, F
    El Tamer, E
    Schere, DB
    Passerieu, M
    Bruno, OD
    Niepomniszcze, H
    MEDICINA-BUENOS AIRES, 2006, 66 (02) : 125 - 130
  • [35] What role for recombinant human TSH in the treatment of metastatic thyroid cancer?
    Zanotti-Fregonara, Paolo
    Hindie, Elif
    Toubert, Marie Elisabeth
    Rubello, Domenico
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (06) : 883 - 885
  • [36] What role for recombinant human TSH in the treatment of metastatic thyroid cancer?
    Paolo Zanotti-Fregonara
    Elif Hindié
    Marie Elisabeth Toubert
    Domenico Rubello
    European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 883 - 885
  • [37] Influence of human body composition on serum peak thyrotropin (TSH) after recombinant human TSH administration in patients with differentiated thyroid carcinoma
    Castagna, MG
    Pinchera, A
    Marsili, A
    Giannetti, M
    Molinaro, E
    Fierabracci, P
    Grasso, L
    Pacini, F
    Santini, F
    Elisei, R
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (07): : 4047 - 4050
  • [38] Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
    Mazzaferri, EL
    Kloos, RT
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04): : 1490 - 1498
  • [39] The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer
    Zygmunt, Arkadiusz
    Krawczyk-Rusiecka, Kinga
    Skowronska-Jozwiak, Elzbieta
    Wojciechowska-Durczynska, Katarzyna
    Glowacka, Ewa
    Adamczewski, Zbigniew
    Lewinski, Andrzej
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [40] Ablation of differentiated thyroid cancer (DTC) with recombinant human TSH (rhTSH): a comparison between 1850 MBq and 3700 MBq of radioiodine
    Capoccetti, F.
    Pacini, F.
    Vattimo, A.
    Berbellini, A.
    Cidda, C.
    Fattori, S.
    Ferretti, F.
    Rossi, G.
    Sivolella, S.
    Pilli, T.
    Guarino, E.
    Burroni, L.
    Castagna, M. G.
    Cipri, C.
    Brianzoni, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S160 - S160
12345